BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 34791403)

  • 21. Management issues in rheumatoid arthritis-associated interstitial lung disease.
    England BR; Hershberger D
    Curr Opin Rheumatol; 2020 May; 32(3):255-263. PubMed ID: 32141954
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Radiological evaluation of interstitial lung disease in patients with rheumatoid arthritis treated with abatacept or JAK inhibitors for 1 year.
    Mochizuki T; Yano K; Ikari K; Okazaki K
    Respir Investig; 2023 May; 61(3):359-363. PubMed ID: 37031622
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessment of Distal Radius Bone Mineral Density in Osteoporosis Patients Receiving Denosumab, Including Those with Rheumatoid Arthritis and Those Receiving Oral Glucocorticoids.
    Matsuno H
    Drugs R D; 2016 Dec; 16(4):347-353. PubMed ID: 27766589
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reinterpreting Evidence of Rheumatoid Arthritis-Associated Interstitial Lung Disease to Understand Etiology.
    Wu EK; Ambrosini RD; Kottmann RM; Ritchlin CT; Schwarz EM; Rahimi H
    Curr Rheumatol Rev; 2019; 15(4):277-289. PubMed ID: 30652645
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tocilizumab therapy in rheumatoid arthritis with interstitial lung disease: a multicentre retrospective study.
    Manfredi A; Cassone G; Furini F; Gremese E; Venerito V; Atzeni F; Arrigoni E; Della Casa G; Cerri S; Govoni M; Petricca L; Iannone F; Salvarani C; Sebastiani M
    Intern Med J; 2020 Sep; 50(9):1085-1090. PubMed ID: 31661185
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Abatacept in interstitial lung disease associated with rheumatoid arthritis: national multicenter study of 263 patients.
    Fernández-Díaz C; Castañeda S; Melero-González RB; Ortiz-Sanjuán F; Juan-Mas A; Carrasco-Cubero C; Casafont-Solé I; Olivé A; Rodríguez-Muguruza S; Almodóvar-González R; Castellanos-Moreira R; Rodríguez-García SC; Aguilera-Cros C; Villa I; Ordóñez-Palau S; Raya-Alvarez E; Morales-Garrido P; Ojeda-García C; Moreno-Ramos MJ; Bonilla Hernán MG; Hernández Rodríguez I; López-Corbeto M; Andreu JL; Jiménez de Aberásturi JRD; Ruibal-Escribano A; Expósito-Molinero R; Pérez-Sandoval T; López-Robles AM; Carreira-Delgado P; Mena-Vázquez N; Urruticoechea-Arana A; Peralta-Ginés C; Arboleya-Rodríguez L; Narváez García FJ; Palma-Sánchez D; Cervantes Pérez EC; Maiz-Alonso O; Alvarez-Rivas MN; Fernández-Melón J; Vela Casasempere P; Cabezas-Rodríguez I; Castellvi-Barranco I; González-Montagut C; Blanco-Madrigal J; Del Val-Del Amo N; Fito MC; Rodríguez-Gómez M; Salgado-Pérez E; García-Magallón B; Hidalgo-Calleja C; López-Sánchez R; Fernández-Aguado S; Fernández-López JC; Castro-Oreiro S; Serrano-García I; García-Valle A; Romero-Yuste S; Expósito-Pérez L; Pérez-Albadalejo L; García-Aparicio A; Quillis-Marti N; Bernal-Vidal JA; Loricera-García J; Hernández JL; González-Gay MA; Blanco R
    Rheumatology (Oxford); 2020 Dec; 59(12):3906-3916. PubMed ID: 33068439
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The serum level and significance of lysyl oxidase-like 2 in patients with rheumatoid arthritis-associated interstitial lung disease.
    Fu Q; Bai Y; Liu Y; Zhou J; Zheng Y
    Clin Rheumatol; 2018 Jan; 37(1):193-198. PubMed ID: 29052023
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Abatacept in patients with rheumatoid arthritis and interstitial lung disease: A national multicenter study of 63 patients.
    Fernández-Díaz C; Loricera J; Castañeda S; López-Mejías R; Ojeda-García C; Olivé A; Rodríguez-Muguruza S; Carreira PE; Pérez-Sandoval T; Retuerto M; Cervantes-Pérez EC; Flores-Robles BJ; Hernández-Cruz B; Urruticoechea A; Maíz-Alonso O; Arboleya L; Bonilla G; Hernández-Rodríguez Í; Palma D; Delgado C; Expósito-Molinero R; Ruibal-Escribano A; Álvarez-Rodríguez B; Blanco-Madrigal J; Bernal JA; Vela-Casasempere P; Rodríguez-Gómez M; Fito C; Ortiz-Sanjuán F; Narváez J; Moreno M; López-Corbeto M; Mena-Vázquez N; Aguilera-Cros C; Romero-Yuste S; Ordóñez S; Villa-Blanco I; Gonzélez-Vela MC; Mora-Cuesta V; Palmou-Fontana N; Hernández JL; González-Gay MA; Blanco R
    Semin Arthritis Rheum; 2018 Aug; 48(1):22-27. PubMed ID: 29422324
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intravenous cyclophosphamide in acute exacerbation of rheumatoid arthritis-related interstitial lung disease: A propensity-matched analysis using a nationwide inpatient database.
    Nakamura K; Ohbe H; Ikeda K; Uda K; Furuya H; Furuta S; Nakajima M; Sasabuchi Y; Matsui H; Fushimi K; Yasunaga H; Nakajima H
    Semin Arthritis Rheum; 2021 Oct; 51(5):977-982. PubMed ID: 34403813
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of Biological Disease-modifying Anti-rheumatic Drugs on Airway and Interstitial Lung Disease in Patients with Rheumatoid Arthritis.
    Kurata I; Tsuboi H; Terasaki M; Shimizu M; Toko H; Honda F; Ohyama A; Yagishita M; Osada A; Ebe H; Kawaguchi H; Takahashi H; Hagiwara S; Asashima H; Kondo Y; Matsumoto I; Sumida T
    Intern Med; 2019 Jun; 58(12):1703-1712. PubMed ID: 30799358
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Factors associated with mortality in rheumatoid arthritis-associated interstitial lung disease: a systematic review and meta-analysis.
    Qiu M; Jiang J; Nian X; Wang Y; Yu P; Song J; Zou S
    Respir Res; 2021 Oct; 22(1):264. PubMed ID: 34635095
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vertebral Fractures Following Denosumab Discontinuation in Patients with Prolonged Exposure to Bisphosphonates.
    Tripto-Shkolnik L; Rouach V; Marcus Y; Rotman-Pikielny P; Benbassat C; Vered I
    Calcif Tissue Int; 2018 Jul; 103(1):44-49. PubMed ID: 29396698
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessment of the effects of switching oral bisphosphonates to denosumab or daily teriparatide in patients with rheumatoid arthritis.
    Ebina K; Hirao M; Hashimoto J; Hagihara K; Kashii M; Kitaguchi K; Matsuoka H; Iwahashi T; Chijimatsu R; Yoshikawa H
    J Bone Miner Metab; 2018 Jul; 36(4):478-487. PubMed ID: 28766140
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mortality in patients with rheumatoid arthritis-associated interstitial lung disease treated with an anti-tumor necrosis factor agent.
    Koo BS; Hong S; Kim YJ; Kim YG; Lee CK; Yoo B
    Korean J Intern Med; 2015 Jan; 30(1):104-9. PubMed ID: 25589842
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Successful Treatment of a Patient with Drug-Refractory Rheumatoid Arthritis-Associated Interstitial Lung Disease with Upadacitinib: A Case Report.
    Nishii Y; Okamoto M; Zaizen Y; Kojima T; Nouno T; Naitou-Nishida Y; Matsuo N; Takeoka H; Ishida M; Nakamura M; Masuda T; Tanaka T; Miyamura T; Hoshino T
    Medicina (Kaunas); 2023 Nov; 59(11):. PubMed ID: 38004009
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy and safety of abatacept in interstitial lung disease of rheumatoid arthritis: A systematic literature review.
    Vicente-Rabaneda EF; Atienza-Mateo B; Blanco R; Cavagna L; Ancochea J; Castañeda S; González-Gay MÁ
    Autoimmun Rev; 2021 Jun; 20(6):102830. PubMed ID: 33887489
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical characteristics associated with occurrence and poor prognosis of interstitial lung disease in rheumatoid arthritis.
    Yang JA; Lee JS; Park JK; Lee EB; Song YW; Lee EY
    Korean J Intern Med; 2019 Mar; 34(2):434-441. PubMed ID: 28352064
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnostic accuracy of a velcro sound detector (VECTOR) for interstitial lung disease in rheumatoid arthritis patients: the InSPIRAtE validation study (INterStitial pneumonia in rheumatoid ArThritis with an electronic device).
    Manfredi A; Cassone G; Cerri S; Venerito V; Fedele AL; Trevisani M; Furini F; Addimanda O; Pancaldi F; Della Casa G; D'Amico R; Vicini R; Sandri G; Torricelli P; Celentano I; Bortoluzzi A; Malavolta N; Meliconi R; Iannone F; Gremese E; Luppi F; Salvarani C; Sebastiani M;
    BMC Pulm Med; 2019 Jun; 19(1):111. PubMed ID: 31221137
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Abatacept in rheumatoid arthritis-associated interstitial lung disease: short-term outcomes and predictors of progression.
    Tardella M; Di Carlo M; Carotti M; Giovagnoni A; Salaffi F
    Clin Rheumatol; 2021 Dec; 40(12):4861-4867. PubMed ID: 34313866
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [An autopsy case of rheumatoid arthritis accompanied with acute exacerbation of interstitial pneumonia].
    Aratake K; Eguchi K; Migita K; Kawabe Y; Matsuoka N; Tominaga M; Nakamura H; Ichinose K; Nagataki S; Toriyama K
    Nihon Rinsho Meneki Gakkai Kaishi; 1998 Jun; 21(3):129-36. PubMed ID: 9754015
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.